The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo
- 3 January 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Prostate Cancer and Prostatic Diseases
- Vol. 9 (2), 147-152
- https://doi.org/10.1038/sj.pcan.4500856
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancerUrological Research, 2004
- Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancerProstate Cancer and Prostatic Diseases, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Curcumin downregulates cell survival mechanisms in human prostate cancer cell linesOncogene, 2001
- Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivoThe Prostate, 2001
- The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasisPathology and Oncology Research, 2001
- Therapeutic potential of curcumin in human prostate cancer—I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cellsProstate Cancer and Prostatic Diseases, 2000
- Diet and its preventive role in prostatic disease.European Urology, 1999
- Nutritional and Socioeconomic Factors in Relation to Prostate Cancer Mortality: a Cross-National StudyJNCI Journal of the National Cancer Institute, 1998
- Matrix MetalloproteinasesDrugs & Aging, 1997